-
-
-
-
-
-
-
BioNTech soars 15% on cancer drug deal with Bristol Myers
-
-
-
-
-
-
-
Demand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus
-
-
-
-
-
-
-
Goldman Sachs Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
-
-
-
-
-
-
-
PureTech Announces Annual Results for Year Ended December 31, 2023
-
-
-
-
-
-
-
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio
-
-
-
-
-
-
-
Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer
-
-
-
-
-
-
-
Bristol Myers Squibb Recommends Stockholders Reject “Mini-Tender” Offer by Tutanota LLC
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

